Shares of Core Laboratories N.V. (NYSE:CLB) have been given an average rating of “Hold” by the seventeen analysts that are covering the firm, MarketBeat Ratings reports. Three equities research analysts have rated the stock with a sell recommendation, eight have given a hold recommendation and six have given a buy recommendation to the company. The average 12 month price objective among analysts that have covered the stock in the last year is $108.30.

Several equities analysts recently issued reports on the stock. Zacks Investment Research raised shares of Core Laboratories N.V. from a “sell” rating to a “hold” rating in a report on Wednesday. Scotiabank set a $136.00 price objective on shares of Core Laboratories N.V. and gave the company a “hold” rating in a report on Wednesday, October 25th. ABN Amro raised shares of Core Laboratories N.V. from a “hold” rating to a “buy” rating in a report on Wednesday, October 25th. UBS AG cut their price objective on shares of Core Laboratories N.V. from $110.00 to $100.00 and set a “neutral” rating on the stock in a report on Wednesday, October 25th. Finally, BidaskClub lowered shares of Core Laboratories N.V. from a “sell” rating to a “strong sell” rating in a report on Monday, August 14th.

TRADEMARK VIOLATION WARNING: This article was posted by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are accessing this article on another domain, it was copied illegally and reposted in violation of U.S. & international copyright and trademark legislation. The legal version of this article can be viewed at https://theolympiareport.com/2017/11/01/brokerages-set-core-laboratories-n-v-clb-price-target-at-108-30.html.

Core Laboratories N.V. (NYSE:CLB) last issued its quarterly earnings data on Monday, October 23rd. The oil and gas company reported $0.48 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.44 by $0.04. The company had revenue of $166.20 million for the quarter, compared to analyst estimates of $160.94 million. Core Laboratories N.V. had a net margin of 12.06% and a return on equity of 52.89%. Core Laboratories N.V.’s revenue was up 1.4% compared to the same quarter last year. During the same period last year, the company posted $0.38 earnings per share.

The company also recently announced a quarterly dividend, which will be paid on Tuesday, November 21st. Shareholders of record on Friday, October 20th will be paid a $0.55 dividend. The ex-dividend date is Thursday, October 19th. This represents a $2.20 annualized dividend and a yield of 2.20%. Core Laboratories N.V.’s dividend payout ratio (DPR) is 126.44%.

A number of institutional investors and hedge funds have recently made changes to their positions in the business. State of Wisconsin Investment Board boosted its stake in Core Laboratories N.V. by 2.3% in the third quarter. State of Wisconsin Investment Board now owns 86,218 shares of the oil and gas company’s stock valued at $8,510,000 after acquiring an additional 1,898 shares in the last quarter. Stevens Capital Management LP acquired a new stake in Core Laboratories N.V. in the third quarter valued at approximately $1,944,000. Country Trust Bank boosted its stake in Core Laboratories N.V. by 50.7% in the third quarter. Country Trust Bank now owns 116,010 shares of the oil and gas company’s stock valued at $11,450,000 after acquiring an additional 39,007 shares in the last quarter. Andra AP fonden boosted its stake in Core Laboratories N.V. by 157.5% in the third quarter. Andra AP fonden now owns 20,600 shares of the oil and gas company’s stock valued at $2,033,000 after acquiring an additional 12,600 shares in the last quarter. Finally, Mcdonald Capital Investors Inc. CA boosted its stake in Core Laboratories N.V. by 27.0% in the third quarter. Mcdonald Capital Investors Inc. CA now owns 312,813 shares of the oil and gas company’s stock valued at $30,875,000 after acquiring an additional 66,441 shares in the last quarter.

About Core Laboratories N.V.

Core Laboratories N.V. provides reservoir description, production enhancement and reservoir management services to the oil and gas industry. The Company operates through three segments: Reservoir Description, Production Enhancement and Reservoir Management. The Reservoir Description segment encompasses the characterization of petroleum reservoir rock, fluid and gas samples.

Analyst Recommendations for Core Laboratories N.V. (NYSE:CLB)

Receive News & Ratings for Core Laboratories N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories N.V. and related companies with Analyst Ratings Network's FREE daily email newsletter.